Search

everythinglearnresearchcommunity

for

Search:↓

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Removing the thymoma improved the man's autoimmune conditions.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Tamoxifen caused hair loss in a 52-year-old woman.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

A substance called sodium zinc dihydrolipoylhistidinate can significantly reduce hair loss caused by chemotherapy in rats.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

Harlequin mutant mice have hair loss due to low AIF protein levels and retroviral element activity.

Norwegian puffin dogs have a unique type of hair loss that often doesn't get better on its own and responds well to ciclosporin treatment.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The article concludes that early treatment of alopecia is crucial to prevent permanent hair loss.

Alopecia in animals can be hereditary, congenital, or acquired, with treatments and outcomes varying widely.

Some alternative treatments for hair loss might work, but more research is needed.

Women using hair relaxers with alopecia had lower zinc levels, suggesting zinc deficiency might contribute to hair loss.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

Narrowband UVB phototherapy alone is not very effective for treating alopecia areata.

Most patients with cicatricial alopecias face significant psychological and social challenges due to their hair loss.

A 73-year-old woman's unusual hair loss and growth led to the discovery of a rare condition causing too much testosterone, which improved after her ovaries were removed.

A new genetic mutation in the ODC1 gene causes developmental delay and other symptoms in a young girl.

People with a common type of hair loss have higher stress levels in their body, and treatments that reduce this stress could help.